NOX-A12 First-in-human (FIH) Study

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
This is the first time NOX-A12 will be administered to man. The principal aim of this study is to obtain safety and tolerability data when NOX-A12 is administered by single intravenous (IV) doses to healthy male and female subjects. This information, together with the pharmacokinetic and pharmacodynamic data, will help establish the doses and dosage regimen of administration suitable for subsequent studies in the patient population.
Epistemonikos ID: 15dde0e7d2e03e1e38ce36dddd34eff0f2e546cf
First added on: May 05, 2024